Carolinas Wealth Consulting’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18
Closed -$1.32K 1080
2023
Q4
$1.32K Buy
18
+1
+6% +$66 ﹤0.01% 796
2023
Q3
$1.07K Sell
17
-2
-11% -$170 ﹤0.01% 820
2023
Q2
$1.76K Buy
+19
New +$1.48K ﹤0.01% 835

Other funds holding EXAS

Carolinas Wealth Consulting's EXAS Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 18 shares — an estimated $1.32K sold.

Carolinas Wealth Consulting first reported a position in EXAS in Q2 2023 and held it in 3 quarters. The position peaked at $1.76K in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 18 Exact Sciences shares in Q1 2024, an estimated $1.32K.
  • Carolinas Wealth Consulting first reported a position in Exact Sciences in Q2 2023 and held it in 3 quarters.
  • Carolinas Wealth Consulting's Exact Sciences position peaked at $1.76K in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.